PLoS Biology (Apr 2019)

Structure of the human ClC-1 chloride channel.

  • Kaituo Wang,
  • Sarah Spruce Preisler,
  • Liying Zhang,
  • Yanxiang Cui,
  • Julie Winkel Missel,
  • Christina Grønberg,
  • Kamil Gotfryd,
  • Erik Lindahl,
  • Magnus Andersson,
  • Kirstine Calloe,
  • Pascal F Egea,
  • Dan Arne Klaerke,
  • Michael Pusch,
  • Per Amstrup Pedersen,
  • Z Hong Zhou,
  • Pontus Gourdon

DOI
https://doi.org/10.1371/journal.pbio.3000218
Journal volume & issue
Vol. 17, no. 4
p. e3000218

Abstract

Read online

ClC-1 protein channels facilitate rapid passage of chloride ions across cellular membranes, thereby orchestrating skeletal muscle excitability. Malfunction of ClC-1 is associated with myotonia congenita, a disease impairing muscle relaxation. Here, we present the cryo-electron microscopy (cryo-EM) structure of human ClC-1, uncovering an architecture reminiscent of that of bovine ClC-K and CLC transporters. The chloride conducting pathway exhibits distinct features, including a central glutamate residue ("fast gate") known to confer voltage-dependence (a mechanistic feature not present in ClC-K), linked to a somewhat rearranged central tyrosine and a narrower aperture of the pore toward the extracellular vestibule. These characteristics agree with the lower chloride flux of ClC-1 compared with ClC-K and enable us to propose a model for chloride passage in voltage-dependent CLC channels. Comparison of structures derived from protein studied in different experimental conditions supports the notion that pH and adenine nucleotides regulate ClC-1 through interactions between the so-called cystathionine-β-synthase (CBS) domains and the intracellular vestibule ("slow gating"). The structure also provides a framework for analysis of mutations causing myotonia congenita and reveals a striking correlation between mutated residues and the phenotypic effect on voltage gating, opening avenues for rational design of therapies against ClC-1-related diseases.